We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.


4 June 2008 By Una Galani

The UK market research firm has agreed an allshare deal with GfK. Yet its German rival comes with big execution risk and a potential poison pill. If WPP even marginally improves its offer to compensate for part payment in its own more volatile paper, TNS should change its tune.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)